Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database

References

• Feldman C, Anderson R. Meningococcal pneumonia: a review. Pneumonia (Nathan). 2019;11:3.
   PubMedGoogle Scholar
• Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Fron Pediatr. 2018;6:321. doi:10.3389/fped.2018.00321.
   PubMed Web of Science ®Google Scholar
• Stephens DS. Neisseria meningitidis. Infect Control. 1985;6:37–40. doi:10.1017/S0195941700062482.
   PubMedGoogle Scholar
• Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(Suppl 2):B51–63. doi:10.1016/j.vaccine.2009.04.063.
   PubMed Web of Science ®Google Scholar
• Vyse A, Anonychuk A, Jakel A, Wieffer H, Nadel S. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11:597–604. doi:10.1586/eri.13.42.
   PubMed Web of Science ®Google Scholar
• Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317–28. doi:10.1016/S1473-3099(10)70048-7.
   PubMed Web of Science ®Google Scholar
• Olbrich KJ, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Therapy. 2018;7:421–38. doi:10.1007/s40121-018-0213-2.
   PubMed Web of Science ®Google Scholar
• Whittaker R, Dias JG, Ramliden M, Kodmon C, Economopoulou A, Beer N, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Vaccine. 2017;35:2034–41.
   PubMed Web of Science ®Google Scholar
• Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, Corton C, Care R, Poolman JT, Zollinger WD, et al. Description and nomenclature of Neisseria meningitidis Capsule Locus. Emerg Infect Dis. 2013;19:566–73. doi:10.3201/eid1904.111799.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC, editor. Annual epidemiological report for 2017. Stockholm: ECDC; 2019.
   Google Scholar
• Isitt C, Cosgrove CA, Ramsay ME, Ladhani SN. Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience. Arch Dis Child. 2020;105:784–90. doi:10.1136/archdischild-2019-318047.
   PubMed Web of Science ®Google Scholar
• Taha MK, Gaudelus J, Deghmane AE, Caron F. Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries. Hum Vaccin Immunother. 2020;1–6.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Kreiner CJ, Shutt KA, Messonnier NE, O’Leary M, Stefonek KR, Lin H, Lynfield R, Barrett NL, Arnold KE, et al. Risk factors for meningococcal disease in students in grades 9-12. Pediatr Infect Dis J. 2008;27:193–99. doi:10.1097/INF.0b013e31815c1b3a.
   PubMed Web of Science ®Google Scholar
• Tully J, Viner RM, Coen PG, Stuart JM, Zambon M, Peckham C, Booth C, Klein N, Kaczmarski E, Booy R, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ (Clin Res Ed). 2006;332:445–50. doi:10.1136/bmj.38725.728472.BE.
   PubMed Web of Science ®Google Scholar
• Olea A, Matute I, Gonzalez C, Delgado I, Poffald L, Pedroni E, Alfaro T, Hirmas M, Nájera M, Gormaz A, et al. Case-control study of risk factors for meningococcal disease in Chile. Emerg Infect Dis. 2017;23:1070–78. doi:10.3201/eid2307.160129.
   PubMed Web of Science ®Google Scholar
• Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, Moore N. The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2017;26:954–62. doi:10.1002/pds.4233.
   PubMed Web of Science ®Google Scholar
• Baujat G, Choquet R, Bouee S, Jeanbat V, Courouve L, Ruel A, Michot C, Le Quan Sang K-H, Lapidus D, Messiaen C, et al. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases. Orphanet J Rare Dis. 2017;12:123. doi:10.1186/s13023-017-0674-5.
   PubMed Web of Science ®Google Scholar
• Cottenet J, Dabakuyo-Yonli TS, Mariet AS, Roussot A, Arveux P, Quantin C. Prevalence of patients hospitalised for male breast cancer in France using the French nationwide hospital administrative database. Eur J Cancer Care (Engl). 2019;28:e13117. doi:10.1111/ecc.13117.
   PubMed Web of Science ®Google Scholar
• Cottin V, Avot D, Levy-Bachelot L, Baxter CA, Ramey DR, Catella L, Bénard S, Sitbon O, Teal S. Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database. PloS One. 2019;14:e0214649. doi:10.1371/journal.pone.0214649.
   PubMed Web of Science ®Google Scholar
• Bergot E, De Leotoing L, Bendjenana H, Tournier C, Vainchtock A, Nachbaur G, Humbert M. Hospital burden of pulmonary arterial hypertension in France. PloS One. 2019;14:e0221211. doi:10.1371/journal.pone.0221211.
   PubMed Web of Science ®Google Scholar
• STIKO. Statement of the German Standing Committee on Vaccination at the RKIRecommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2017/201. Epid Bull. 2017;34:333–76.
   Google Scholar
• Direction Générale de la Santé. Calendrier des vaccinations et recommandations vaccinales 2019. 2.9 Infections invasives à méningocoque (IIM). 2019.
   Google Scholar
• National Health Service. Complete immunisation schedule. London, UK: NHS; 2018.
   Google Scholar
• Direzione Generale della PrevenzioneSanitariadel Ministero della Salute. Piano Nazionale Prevenzione Vaccinale. PNPV 2017-2019. 2017.
   Google Scholar
• Asociación Española de Pediatría. Manual de vacunas en línea de la AEP. Capítulo 30 - meningococos. 2019.
   Google Scholar
• Sorensen HT, Labouriau R, Jensen ES, Mortensen PB, Schonheyder HC. Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal disease: a nationwide case-control study. Int J Epidemiol. 2004;33:816–20. doi:10.1093/ije/dyh169.
   PubMed Web of Science ®Google Scholar
• Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, van der Werf S, Alonso J-M, Naffakh N, Taha M-K. Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun. 2009;77:3588–95. doi:10.1128/IAI.00155-09.
   PubMed Web of Science ®Google Scholar
• Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso J-M. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37:1639–42. doi:10.1086/379719.
   PubMed Web of Science ®Google Scholar
• Rey G, Jougla E, Fouillet A, Hemon D. Ecological association between a deprivation index and mortality in France over the period 1997-2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death. BMC Public Health. 2009;9:33. doi:10.1186/1471-2458-9-33.
   PubMed Web of Science ®Google Scholar
• Parent Du Chatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, Lévy-Bruhl D. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015. J Infect. 2017;74:564–74. doi:10.1016/j.jinf.2017.02.011.
   PubMed Web of Science ®Google Scholar
• Taha MK, Alonso JM, Cafferkey M, Caugant DA, Clarke SC, Diggle MA, Fox A, Frosch M, Gray SJ, Guiver M, et al. Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol. 2005;43:144–49. doi:10.1128/JCM.43.1.144-149.2005.
   PubMed Web of Science ®Google Scholar
• Dinleyici EC, Borrow R. Meningococcal infections among refugees and immigrants: silent threats of past, present and future. Hum Vaccin Immunother. 2020;1–6.
   PubMed Web of Science ®Google Scholar
• Broker M, Emonet S, Fazio C, Jacobsson S, Koliou M, Kuusi M, Pace D, Paragi M, Pysik A, Simões MJ, et al. Meningococcal serogroup Y disease in Europe: continuation of high importance in some European regions in 2013. Hum Vaccin Immunother. 2015;11:2281–86. doi:10.1080/21645515.2015.1051276.
   PubMed Web of Science ®Google Scholar
• Miller L, Arakaki L, Ramautar A, Bodach S, Braunstein SL, Kennedy J, Steiner-Sichel L, Ngai S, Shepard C, Weiss D, et al. Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med. 2014;160:30–37. doi:10.7326/0003-4819-160-1-201401070-00731.
   PubMed Web of Science ®Google Scholar
• Simmons RD, Kirwan P, Beebeejaun K, Riordan A, Borrow R, Ramsay ME, Delpech V, Lattimore S, Ladhani S. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study. BMC Med. 2015;13:297. doi:10.1186/s12916-015-0538-6.
   PubMed Web of Science ®Google Scholar
• Winstead JM, McKinsey DS, Tasker S, De Groote MA, Baddour LM. Meningococcal pneumonia: characterization and review of cases seen over the past 25 years. Clin Infect Dis. 2000;30:87–94. doi:10.1086/313617.
   PubMed Web of Science ®Google Scholar
• Burgess S. Social and environmental influences affecting the risk of development of meningococcal disease: considerations for prehospital care. J Emerg Prim Health Care. 2006;4:1–10.
   Google Scholar
• Heyderman RS, Ben-Shlomo Y, Brennan CA, Somerset M. The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics. Arch Dis Child. 2004;89:1064–68. doi:10.1136/adc.2003.036004.
   PubMed Web of Science ®Google Scholar
• Williams CJ, Willocks LJ, Lake IR, Hunter PR. Geographic correlation between deprivation and risk of meningococcal disease: an ecological study. BMC Public Health. 2004;4:30. doi:10.1186/1471-2458-4-30.
   PubMed Web of Science ®Google Scholar